6Closing the Gap: The Electrode-Neuron Interface

FWhy channels interact: the gap, the perilymph, and current spread

A contact sits in scala tympani, but the target neurons sit in the modiolus; in between lies conductive perilymph and bone — the electrode-neuron gap. Current injected into this conductive medium spreads broadly, so a single contact excites a wide swathe of neurons and neighbouring contacts excite overlapping populations. This overlap is channel interaction: it blurs the place-frequency code the implant is trying to deliver and is a key reason speech-in-noise, music and pitch perception remain hard. Neural survival matters too — where spiral ganglion neurons have died, even a perfectly placed contact addresses a hole in the map, so the interface quality is patient- and site-specific.[2010]

TFocus the current: fewer but cleaner channels

Tripolar and partial-tripolar configurations return current to flanking contacts, squeezing the field into a narrower spread of excitation than monopolar stimulation; phased-array and current-focusing schemes pursue the same goal. Focusing comes at a cost: it needs more current, and where neurons have degenerated, that extra current can spill into adjacent regions — focused thresholds and tuning curves can flag a channel with a poor interface. Clinically, the payoff has been mixed: across studies, current focusing has only sometimes improved speech perception, reflecting how strongly the interface varies between users. A practical lesson is fewer-but-cleaner: identifying and deactivating or focusing channels with the worst interface can improve perception more than using every contact indiscriminately.[2010][2016]

CMove the contacts into the nerve: intraneural arrays (preclinical)

If the gap is the problem, one answer is to abolish it — place penetrating contacts directly inside the auditory nerve so current need not cross perilymph at all. In animal models, an intraneural penetrating array produced far more restricted tonotopic spread, lower thresholds and reduced interference between simultaneously stimulated channels than an intrascalar array. Because each penetrating contact addresses a tighter fibre population, an intraneural design could in principle support many more truly independent channels than the cochlear lumen allows. This is firmly preclinical: penetrating the nerve risks mechanical and neural injury, and no human auditory-nerve penetrating array is in clinical use — it remains a research direction, not a clinic-now option.[2008]

CPull the nerve to the contacts: neurite bridging (preclinical)

The third strategy is biological: rather than moving electrodes into the nerve, induce the nerve's peripheral processes to regrow toward the array, shrinking the gap from the neural side. Neurotrophins (BDNF, NT-3) promote spiral ganglion neuron survival and neurite outgrowth; delivered near the array, they can draw processes toward the contacts. Close-field electroporation used the implant's own contacts to deliver a BDNF gene into nearby cells; auditory-nerve peripheral processes regrew toward the array, lowering thresholds and widening the dynamic range in animals. This is the convergence point of the chapter: a drug/gene-eluting next-generation array that bridges its own electrode-neuron gap — promising, but preclinical.[2014][2006]